PT Inti Central Pharma (Indonesia)

Inti Central Pharma is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Barat. The company was founded in 2009. Inti Central Pharma was established by a group of visionary entrepreneurs with a mission to provide high-quality pharmaceutical products to the Indonesian market. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. Inti Central Pharma operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. The company has also expanded its operations to include a state-of-the-art manufacturing facility in Jawa Barat, which adheres to international standards of quality and safety. The company's product portfolio includes a variety of therapeutic categories, such as antibiotics, analgesics, and cardiovascular drugs. Some of its well-known brands include IntiMed, a line of pain relief medications, and VitaPlus, a range of health supplements. Inti Central Pharma is committed to expanding its global footprint and currently exports its products to several countries in Southeast Asia, including Malaysia, Thailand, and Vietnam. The company has established strategic partnerships with international pharmaceutical firms to enhance its research and development capabilities. As a member of the Indonesian Pharmaceutical Association, Inti Central Pharma actively participates in industry initiatives and collaborates with government agencies to improve healthcare access and quality in the region. The company's vision is to become a leading pharmaceutical provider in Asia, driven by innovation, quality, and a commitment to improving patient outcomes.